Sangrix SGRX
NASDAQ SGRX
$1.67 +0.16 (+10.60%)
As of: Sep 30, 2026 · 1:35 PM EDT

Sangrix Inc. (SGRX) Current Deferred Revenue (2018 - 2021)

Updated

Sangrix (SGRX) posted Current Deferred Revenue of $4.7 million for fiscal Q2 2022 (quarter ended Dec 31, 2021), down 60.9% from $12.02 million a year earlier.

Analysis

Sangrix Inc. (SGRX) Current Deferred Revenue (2018 - 2021) Analysis & Trends

At the end of FY2021 (ended Jun 30, 2021), Sangrix's Current Deferred Revenue came in at $4.39 million, up 278.7% from FY2020.

  • Annual Current Deferred Revenue has increased for three consecutive fiscal years, with a three-year compound annual growth rate of 88.7% (FY2018 to FY2021).
  • In prior fiscal years, Sangrix's Current Deferred Revenue was $1.16 million in FY2020 (+64.7%), $704,354 in FY2019 (+7.7%) and $654,117 in FY2018.
  • Quarterly Current Deferred Revenue has run from a low of $428,605 in fiscal Q2 2019 to a high of $12.02 million in fiscal Q2 2021 over five years.
Peer Set

Peer Comparison

Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2021 4.70 Mn
Jun 30, 2021 4.39 Mn
Dec 31, 2020 12.02 Mn
Jun 30, 2020 1.16 Mn
Dec 31, 2019 671,893.00
Jun 30, 2019 704,354.00
Dec 31, 2018 428,605.00
Jun 30, 2018 654,117.00
API Access

Sangrix Inc. Current Deferred Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=SGRX&period=max&api_key=YOUR_API_KEY